International nonproprietary name:
Included in the enzymes nandrolone phenylpropionate lipase, amylase and protease facilitate the digestion of fats, carbohydrates and proteins, which contributes to a more complete absorption in the small intestine.
Indications for use
Insufficiency of exocrine function of the pancreas (chronic pancreatitis, cystic fibrosis, etc.).
Chronic inflammatory and degenerative diseases of the stomach, intestines, liver, gallbladder. Status after resection or irradiation of these organs, accompanied by impaired digestion of food, flatulence, diarrhea (in a combination therapy).
To improve food digestion in patients with normal function of the gastrointestinal tract in the case of errors in nutrition, as well as violations of the chewing function, forced prolonged immobilization, sedentary lifestyle.
Preparing to X-ray and ultrasound examination of the abdominal cavity.
: Hypersensitivity to the drug, acute pancreatitis, exacerbation of chronic pancreatitis, children up to 3 years.
Pregnancy and lactation
The safety of nandrolone phenylpropionate during pregnancy has been poorly studied. Application is possible in cases where the expected benefit to the mother outweighs the potential risk to the fetus. During lactation the use of nandrolone phenylpropionate is not contraindicated.
Dosage and administration
The dose is determined individually, depending on the degree of digestive disorders. Adults (in the absence of other regulations): 1 – 4 tablets during meals, without chewing and drinking plenty of fluids. Do not exceed the recommended daily dose of the enzymes constituting 15,000 FIP lipase units per kg body weight.
In children, the drug is used on doctor’s prescription. Usually assigned to 1 tablet 3 times a day during meals.
The duration of treatment may vary from single dose or several days (at violation errors due to the digestion process in the diet) to a few months, years yli (permanent replacement therapy, if necessary).
: Allergic reactions (sneezing, watery eyes, skin rashes). Rarely – diarrhea or constipation, nausea, discomfort in the epigastric region. With prolonged use at high doses may develop hyperuricosuria, increased levels of uric acid in blood plasma. In cystic fibrosis in the case of excess of the required dose of nandrolone phenylpropionate may develop strictures (fibrous colonopathy) in the ileocecal department and ascending colon.
In the application of nandrolone phenylpropionate in high doses may occur in children perianal irritation and irritation of the oral mucosa.
Overdose Symptoms: hyperuricosuria, hyperuricemia. The children – constipation. Treatment: removal of the drug, symptomatic therapy.
Interaction with other drugs
With simultaneous application of nandrolone phenylpropionate with iron preparations may decrease the absorption of the latter. The simultaneous use of antacids containing calcium carbonate and / or magnesium hydroxide, can reduce the effectiveness of nandrolone phenylpropionate.
Prolonged use at the same time prescribe iron supplements.
Tablets are enteric coated. 10 tablets in PVC / aluminum blister. In 2 or 5 blisters with instruction on use are placed in a stack of cardboard. Sustanon 250 for sale, buying sustanon 250 organon sustanon 250.